Remote Medical Technologies’ iMedHD2™ Telepathology System Validated for Fine and Transbronchial Needle Aspirations
Fostering a true team approach with discussions between pathologists, gastroenterologists, and surgeons taking place in live, real-time to collaborate on diagnoses.
Melville, New York (PRWEB) July 08, 2014
Remote Medical Technologies, LLC. (RMT) has advanced the iMedHD2™ Telepathology and Ultrasound Systems for use with fine needle aspirations (FNA) and transbronchial needle aspirations (TBNA). The stages in which biopsies are being performed are now changing due to the use of this innovative system. Prolonged patient anxiety, insufficient cellularity, and the inability for doctors of different disciplines to communicate effectively in real-time for the benefit of the patient are aspects of this procedure that we are seeing being phased out. Immediate diagnoses for such procedures are being given by pathologists, gastroenterologists, and surgeons due to the ease of use of the iMedHD2™ Telepathology and Ultrasound System.
These systems allow doctors to securely stream and collaborate on high definition images and video, which can be integrated with existing LIS, HIS, EMR, and HER systems, in real-time as soon as material is aspirated for histological analysis. CEO and Founder of RMT, Don Marchon, states, “Patients appreciate the fact that they are receiving the best immediate care, advice and instructions from cross specialty medical experts. This results in better patient treatments, outcomes, and significant cost saving benefits to the medical facility.” The ability to capture snapshots and record video with audio to be shared with colleagues anywhere, be it in the same hospital or in another city, is a great solution for problematic cells and false negative results. Regardless of biopsies performed on a mass or ultrasound guided fine needle biopsies, once the cells are extracted, a technician can quickly place a stained slide under a microscope for immediate shared analysis.
Remote Medical Technologies is the creator of an innovative patented technology for delivery of Internet-based premium telemedicine services. The company is a Limited Liability Corporation headquartered in New York. RMT provides a best-in-class web-based video, voice, collaboration and administration platform. With simply the use of a browser the solution is easy to deploy, operate and manage. This customization and extendable multimedia services platform is a modular, non-fragmented approach to extending a healthcare organization’s communications infrastructure. Be it across the street or around the globe, RMT drives telemedicine concepts and provides solutions that save lives.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/07/prweb12001132.htm